Literature DB >> 8671774

How to diagnose and correct iron deficiency during r-huEPO therapy--a consensus report.

W H Hörl1, I Cavill, I C MacDougall, R M Schaefer, G Sunder-Plassmann.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8671774     DOI： 10.1093/oxfordjournals.ndt.a027248

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN： 0931-0509            Impact factor:   5.992


× No keyword cloud information.
  5 in total

1.  A study of the response of elderly patients with end-stage renal disease to epoetin alfa or beta.

Authors:  Johann C B Nicholas
Journal:  Drugs Aging       Date:  2004       Impact factor: 3.923

Review 2.  [Indications and practical management of parenteral iron therapy].

Authors:  Markus Kosch; Roland M Schaefer
Journal:  Wien Klin Wochenschr       Date:  2003-06-24       Impact factor: 1.704

3.  Comparison of reticulocyte hemoglobin equivalent with traditional markers of iron and erythropoiesis in pediatric dialysis.

Authors:  Sarka Davidkova; Timothy D Prestidge; Peter W Reed; Tonya Kara; William Wong; Chanel Prestidge
Journal:  Pediatr Nephrol       Date:  2015-12-14       Impact factor: 3.714

Review 4.  Should we reconsider iron administration based on prevailing ferritin and hepcidin concentrations?

Authors:  Takeshi Nakanishi; Takahiro Kuragano; Shoji Kaibe; Yasuyuki Nagasawa; Yukiko Hasuike
Journal:  Clin Exp Nephrol       Date:  2012-09-29       Impact factor: 2.801

5.  Modified recombinant human erythropoietin with potentially reduced immunogenicity.

Authors:  Thanutsorn Susantad; Mayuree Fuangthong; Kannan Tharakaraman; Phanthakarn Tit-Oon; Mathuros Ruchirawat; Ram Sasisekharan
Journal:  Sci Rep       Date:  2021-01-15       Impact factor: 4.379
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.